Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPEN-LABEL INDUCTION AND MAINTENANCE STUDY OF ORAL CP-690,550 (TOFACITINIB) IN CHILDREN WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

NCT04624230 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04624230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04624230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPEN-LABEL INDUCTION AND MAINTENANCE STUDY OF ORAL CP-690,550 (TOFACITINIB) IN CHILDREN WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Active, not recruiting
Start date
August 12, 2021
Completion date
June 6, 2029
Enrollment
118 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis